532 related articles for article (PubMed ID: 27636542)
1. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
6. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B; Coulibaly JT; Hatz C; Keiser J
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005400. PubMed ID: 28222149
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
Taylor P; Murare HM; Manomano K
J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
[TBL] [Abstract][Full Text] [Related]
11. Bayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'Ivoire.
Chammartin F; Houngbedji CA; Hürlimann E; Yapi RB; Silué KD; Soro G; Kouamé FN; N Goran EK; Utzinger J; Raso G; Vounatsou P
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3407. PubMed ID: 25522007
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
N'Goran EK; Odiere MR; Assandé Aka R; Ouattara M; Aka NAD; Ogutu B; Rawago F; Bagchus WM; Bödding M; Kourany-Lefoll E; Tappert A; Yin X; Bezuidenhout D; Badenhorst H; Huber E; Dälken B; Haj-Ali Saflo O
Lancet Infect Dis; 2023 Jul; 23(7):867-876. PubMed ID: 36893784
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.
Raso G; N'Goran EK; Toty A; Luginbühl A; Adjoua CA; Tian-Bi NT; Bogoch II; Vounatsou P; Tanner M; Utzinger J
Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):18-27. PubMed ID: 14702835
[TBL] [Abstract][Full Text] [Related]
16. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
[TBL] [Abstract][Full Text] [Related]
17. Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
Assaré RK; Tian-Bi YN; Yao PK; N'Guessan NA; Ouattara M; Yapi A; Coulibaly JT; Meïté A; Hürlimann E; Knopp S; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004329. PubMed ID: 26789749
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
Keiser J; Silué KD; Adiossan LK; N'Guessan NA; Monsan N; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2975. PubMed ID: 25033291
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.
Stete K; Krauth SJ; Coulibaly JT; Knopp S; Hattendorf J; Müller I; Lohourignon LK; Kern WV; N'goran EK; Utzinger J
Parasit Vectors; 2012 Dec; 5():298. PubMed ID: 23259435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
